28.55
Invesco Nasdaq Biotechnology Etf (IBBQ) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 |
| Revenues |
8.24%
1,640.40
|
1,515.50 |
| Operating Expenses |
5.24%
1,369.50
|
1,301.30 |
| Benefits Costs and Expenses |
4.24%
1,293.70
|
1,241.10 |
| Costs And Expenses |
4.24%
1,293.70
|
1,241.10 |
| Operating Income/Loss |
26.47%
270.90
|
214.20 |
| Income/Loss Before Equity Method Investments |
25.06%
311.90
|
249.40 |
| Income/Loss From Equity Method Investments |
39.20%
34.80
|
25.00 |
| Income/Loss From Continuing Operations Before Tax |
26.35%
346.70
|
274.40 |
| Income Tax Expense/Benefit |
112.60%
-9.70
|
77.00 |
| Income/Loss From Continuing Operations After Tax |
80.55%
356.40
|
197.40 |
|
|
80.55%
356.40
|
197.40 |
| Preferred Stock Dividends And Other Adjustments |
21.55%
44.40
|
56.60 |
| Attributable To Noncontrolling Interest |
278.33%
10.70
|
-6.00 |
| Basic Average Shares |
0.31%
452.40
|
453.80 |
| Diluted Average Shares |
0.13%
454.60
|
455.20 |
| Basic Earnings Per Share |
2,333%
0.67
|
-0.03 |
| Diluted Earnings Per Share |
2,300%
0.66
|
-0.03 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
21.55%
44.40
|
56.60 |
자본화:
|
볼륨(24시간):